AGIOS PHARMACEUTICALS INC's ticker is and the CUSIP is 00847X954. A total of 4 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,004 | +1.9% | 40,600 | +16.7% | 0.00% | 0.0% |
| Q2 2023 | $985 | +97.8% | 34,800 | +60.4% | 0.00% | – |
| Q1 2023 | $498 | -67.7% | 21,700 | -60.5% | 0.00% | -100.0% |
| Q4 2022 | $1,541 | -100.0% | 54,900 | -54.0% | 0.00% | -50.0% |
| Q3 2022 | $3,376,000 | +293.9% | 119,400 | +208.5% | 0.00% | +300.0% |
| Q2 2022 | $857,000 | +339.5% | 38,700 | +477.6% | 0.00% | – |
| Q1 2022 | $195,000 | -38.1% | 6,700 | -30.2% | 0.00% | – |
| Q4 2021 | $315,000 | -75.1% | 9,600 | -57.1% | 0.00% | -100.0% |
| Q3 2021 | $1,263,000 | +2.4% | 22,400 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,234,000 | -27.6% | 22,400 | +6687.9% | 0.00% | -66.7% |
| Q1 2021 | $1,704,000 | +18.2% | 330 | -0.9% | 0.00% | +50.0% |
| Q4 2020 | $1,442,000 | +984.2% | 333 | +776.3% | 0.00% | – |
| Q3 2020 | $133,000 | -50.2% | 38 | -24.0% | 0.00% | – |
| Q2 2020 | $267,000 | +6.4% | 50 | -29.6% | 0.00% | – |
| Q1 2020 | $251,000 | -89.1% | 71 | -85.2% | 0.00% | -100.0% |
| Q4 2019 | $2,296,000 | -14.9% | 481 | -42.3% | 0.01% | -37.5% |
| Q3 2019 | $2,698,000 | -12.7% | 833 | +34.4% | 0.01% | 0.0% |
| Q2 2019 | $3,092,000 | -19.6% | 620 | +8.8% | 0.01% | -27.3% |
| Q1 2019 | $3,844,000 | +67.4% | 570 | +14.5% | 0.01% | +57.1% |
| Q4 2018 | $2,296,000 | -16.4% | 498 | +39.9% | 0.01% | -22.2% |
| Q3 2018 | $2,745,000 | -14.7% | 356 | -6.8% | 0.01% | -30.8% |
| Q2 2018 | $3,217,000 | +15219.0% | 382 | +35.0% | 0.01% | +1200.0% |
| Q1 2018 | $21,000 | -80.6% | 283 | +139.8% | 0.00% | -80.0% |
| Q4 2017 | $108,000 | +881.8% | 118 | +103.4% | 0.01% | – |
| Q3 2017 | $11,000 | -80.0% | 58 | -35.6% | 0.00% | -100.0% |
| Q2 2017 | $55,000 | +189.5% | 90 | -20.4% | 0.00% | +100.0% |
| Q1 2017 | $19,000 | +90.0% | 113 | +109.3% | 0.00% | 0.0% |
| Q4 2016 | $10,000 | -93.3% | 54 | -92.3% | 0.00% | -90.0% |
| Q3 2016 | $149,000 | -3.2% | 700 | +669.2% | 0.01% | 0.0% |
| Q2 2016 | $154,000 | +123.2% | 91 | +727.3% | 0.01% | +66.7% |
| Q1 2016 | $69,000 | +6800.0% | 11 | +175.0% | 0.01% | – |
| Q4 2015 | $1,000 | -98.1% | 4 | -89.7% | 0.00% | -100.0% |
| Q3 2015 | $54,000 | +116.0% | 39 | -61.0% | 0.00% | +100.0% |
| Q2 2015 | $25,000 | +400.0% | 100 | +1900.0% | 0.00% | +100.0% |
| Q1 2015 | $5,000 | -58.3% | 5 | -97.2% | 0.00% | 0.0% |
| Q4 2014 | $12,000 | – | 181 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 24,100 | $1,044,000 | 0.00% |
| SIMPLEX TRADING, LLC | 333 | $1,442,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 62,100 | $2,691,000 | 0.00% |